Invicta Diagnostic Limited (NSE:INVICTA)
68.15
+1.40 (2.10%)
At close: Jul 31, 2026
-31.85% (1Y)
| Market Cap | 856.78M |
| Revenue (ttm) | 330.42M +382.9% |
| Net Income | 49.06M |
| EPS | 4.90 |
| Shares Out | 12.57M |
| PE Ratio | 13.91 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16,000 |
| Open | 66.00 |
| Previous Close | 66.75 |
| Day's Range | 66.00 - 68.80 |
| 52-Week Range | 58.10 - 105.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 25, 2026 |